← Leaderboards
Peter R Rhode
Altor Bioscience Corporation
$2,659,783
Attributed
$2,659,783
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $999.9K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,659,783 · 5
By mechanism
R44$1,999,838 · 1
R43$659,945 · 4
Top collaborators
No co-investigators on record.
Most similar at Altor Bioscience Corporation
Same institution · by research overlap
- Hing C. Wong$14,637,090
Others in their field
Top investigators on “Chimeric Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Mohamed H Sayegh · University Of Pennsylvania$26,754,200
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$26,234,170
- Robert A Wood · Johns Hopkins University$24,963,233
- Larry Arthur$22,516,306
- Anne Moscona · Mount Sinai School Of Medicine Of Nyu$17,953,641
Research focus
Chimeric ProteinsMalignant NeoplasmsComplexImmunotherapyInterleukin-15 ReceptorInterleukin-2DoseDrug KineticsImmuneImmunotherapeutic AgentAnimal ModelInterleukin-15Clinical TrialsAntitumor ResponseEventCytokineBaseCancer PatientExhibitsCd8b1 GeneCellsImmune ResponseInterferonsMutant
Grant awards (6)
Novel IL-15 Superagonist Therapy for Bladder Cancer$999,919
R44 · FY2018 · CA · contact PI
Novel IL-15 Superagonist Therapy for Bladder Cancer$999,919
R44 · FY2017 · CA · contact PI
Soluble TCR-IL15 Fusions as Targeted Therapeutics for Cancer$202,736
R43 · FY2009 · CA · contact PI
NOVEL DRUG DISCOVERY FOR RHEUMATOID ARTHRITIS$112,209
R43 · FY2005 · AR
NOVEL DRUG DISCOVERY FOR MULTIPLE SCLEROSIS$100,000
R43 · FY2003 · NS
STAINING REAGENTS FOR DETECTING AUTOREACTIVE CD4 T CELLS$245,000
R43 · FY2000 · AI